Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrium | 86 | 2020 | 120 | 17.530 |
Why?
|
Endometriosis | 53 | 2020 | 66 | 10.980 |
Why?
|
Embryo Implantation | 31 | 2020 | 35 | 7.910 |
Why?
|
Infertility, Female | 22 | 2019 | 27 | 5.990 |
Why?
|
Progesterone | 22 | 2019 | 76 | 3.260 |
Why?
|
Uterine Diseases | 9 | 2019 | 15 | 2.710 |
Why?
|
Luteal Phase | 11 | 2016 | 17 | 2.600 |
Why?
|
Fertilization in Vitro | 6 | 2018 | 20 | 2.450 |
Why?
|
Pregnancy | 32 | 2020 | 799 | 2.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 4 | 2019 | 6 | 2.100 |
Why?
|
Female | 111 | 2020 | 17679 | 1.990 |
Why?
|
Abortion, Habitual | 5 | 2018 | 5 | 1.820 |
Why?
|
Polycystic Ovary Syndrome | 7 | 2011 | 19 | 1.720 |
Why?
|
Humans | 108 | 2020 | 28304 | 1.480 |
Why?
|
Integrin beta3 | 6 | 2017 | 9 | 1.480 |
Why?
|
Embryo Transfer | 4 | 2019 | 9 | 1.420 |
Why?
|
Endometrial Neoplasms | 10 | 2017 | 34 | 1.280 |
Why?
|
Uterus | 9 | 2018 | 74 | 1.260 |
Why?
|
Adult | 50 | 2020 | 8243 | 1.220 |
Why?
|
Estrogens | 9 | 2015 | 170 | 1.160 |
Why?
|
Chorionic Gonadotropin | 4 | 2016 | 9 | 1.090 |
Why?
|
Gene Expression Regulation | 15 | 2020 | 467 | 1.090 |
Why?
|
Menstrual Cycle | 14 | 2017 | 28 | 1.080 |
Why?
|
Ovulation Induction | 4 | 2019 | 8 | 1.070 |
Why?
|
Biopsy | 9 | 2017 | 240 | 0.990 |
Why?
|
Integrin alphaVbeta3 | 4 | 2014 | 7 | 0.900 |
Why?
|
Receptors, Progesterone | 7 | 2018 | 44 | 0.880 |
Why?
|
Animals | 36 | 2020 | 6402 | 0.880 |
Why?
|
Clomiphene | 3 | 2011 | 5 | 0.880 |
Why?
|
Pelvic Pain | 4 | 2018 | 17 | 0.860 |
Why?
|
Reproductive Techniques, Assisted | 3 | 2019 | 5 | 0.840 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 10 | 0.810 |
Why?
|
Immunohistochemistry | 18 | 2018 | 515 | 0.810 |
Why?
|
Inflammation | 8 | 2020 | 501 | 0.800 |
Why?
|
Sirtuin 1 | 2 | 2020 | 36 | 0.790 |
Why?
|
Surrogate Mothers | 1 | 2020 | 1 | 0.770 |
Why?
|
Case-Control Studies | 15 | 2020 | 886 | 0.770 |
Why?
|
Reproductive Control Agents | 2 | 2016 | 2 | 0.750 |
Why?
|
Cell Adhesion Molecules | 4 | 2014 | 44 | 0.730 |
Why?
|
STAT3 Transcription Factor | 2 | 2016 | 21 | 0.710 |
Why?
|
Pregnancy Outcome | 2 | 2016 | 52 | 0.700 |
Why?
|
Ovarian Diseases | 1 | 2018 | 8 | 0.690 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2018 | 41 | 0.650 |
Why?
|
Complement System Proteins | 1 | 2017 | 9 | 0.640 |
Why?
|
Pregnancy Rate | 4 | 2019 | 9 | 0.610 |
Why?
|
MicroRNAs | 3 | 2019 | 170 | 0.590 |
Why?
|
Young Adult | 19 | 2020 | 2321 | 0.590 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2016 | 3 | 0.580 |
Why?
|
Papio | 10 | 2020 | 87 | 0.570 |
Why?
|
Stromal Cells | 9 | 2020 | 72 | 0.560 |
Why?
|
Leukemia Inhibitory Factor | 2 | 2018 | 4 | 0.540 |
Why?
|
Adenocarcinoma | 4 | 2015 | 299 | 0.530 |
Why?
|
Mice | 17 | 2020 | 2181 | 0.520 |
Why?
|
Transcription Factors | 4 | 2020 | 175 | 0.520 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2013 | 161 | 0.490 |
Why?
|
Cytokines | 8 | 2019 | 239 | 0.480 |
Why?
|
Homeostasis | 1 | 2014 | 140 | 0.480 |
Why?
|
Fertility | 4 | 2017 | 19 | 0.470 |
Why?
|
Methylene Blue | 1 | 2012 | 3 | 0.460 |
Why?
|
Ovulation Prediction | 1 | 2012 | 1 | 0.460 |
Why?
|
Integrins | 4 | 2010 | 18 | 0.450 |
Why?
|
Staining and Labeling | 1 | 2012 | 55 | 0.450 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2010 | 102 | 0.440 |
Why?
|
Transforming Growth Factor beta | 3 | 2002 | 65 | 0.440 |
Why?
|
Signal Transduction | 10 | 2020 | 607 | 0.440 |
Why?
|
Aromatase Inhibitors | 1 | 2012 | 6 | 0.430 |
Why?
|
Adolescent | 17 | 2020 | 3184 | 0.430 |
Why?
|
Nitriles | 1 | 2012 | 21 | 0.430 |
Why?
|
Triazoles | 1 | 2012 | 12 | 0.430 |
Why?
|
Endometrial Hyperplasia | 3 | 2009 | 14 | 0.420 |
Why?
|
Prospective Studies | 7 | 2017 | 1932 | 0.420 |
Why?
|
Ovulation | 1 | 2011 | 6 | 0.420 |
Why?
|
Women's Health | 1 | 2013 | 226 | 0.410 |
Why?
|
RNA, Messenger | 11 | 2017 | 498 | 0.410 |
Why?
|
Neovascularization, Pathologic | 5 | 2019 | 82 | 0.410 |
Why?
|
Sialoglycoproteins | 4 | 2003 | 7 | 0.400 |
Why?
|
Steroids | 3 | 2006 | 36 | 0.390 |
Why?
|
Cell Line, Tumor | 6 | 2017 | 659 | 0.380 |
Why?
|
Gonadotropin-Releasing Hormone | 3 | 2019 | 9 | 0.370 |
Why?
|
Estrogen Receptor alpha | 3 | 2007 | 52 | 0.370 |
Why?
|
Down-Regulation | 6 | 2017 | 138 | 0.370 |
Why?
|
Anaphylatoxins | 1 | 2009 | 1 | 0.370 |
Why?
|
Complement C3a | 1 | 2009 | 2 | 0.370 |
Why?
|
Epithelial Cells | 7 | 2020 | 139 | 0.360 |
Why?
|
Abortion, Spontaneous | 2 | 2019 | 8 | 0.350 |
Why?
|
Prunella | 1 | 2008 | 1 | 0.340 |
Why?
|
Laparoscopy | 5 | 2015 | 169 | 0.340 |
Why?
|
Drugs, Chinese Herbal | 1 | 2008 | 7 | 0.340 |
Why?
|
Estrogen Receptor Modulators | 1 | 2008 | 23 | 0.340 |
Why?
|
Receptors, Vitronectin | 3 | 2002 | 4 | 0.340 |
Why?
|
Live Birth | 2 | 2019 | 5 | 0.330 |
Why?
|
Disease Progression | 4 | 2020 | 566 | 0.330 |
Why?
|
Disease Models, Animal | 8 | 2019 | 915 | 0.330 |
Why?
|
Retrospective Studies | 8 | 2020 | 2930 | 0.330 |
Why?
|
Risk Factors | 5 | 2020 | 3520 | 0.330 |
Why?
|
Dysmenorrhea | 2 | 2018 | 3 | 0.320 |
Why?
|
Hormones | 2 | 2007 | 20 | 0.320 |
Why?
|
Hydrocarbons, Fluorinated | 2 | 2018 | 4 | 0.320 |
Why?
|
Peritoneal Diseases | 2 | 2020 | 4 | 0.320 |
Why?
|
Genital Diseases, Female | 1 | 2007 | 5 | 0.320 |
Why?
|
Receptor, Notch1 | 2 | 2020 | 8 | 0.320 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 28 | 0.320 |
Why?
|
Decidua | 6 | 2019 | 18 | 0.310 |
Why?
|
Immediate-Early Proteins | 1 | 2007 | 9 | 0.310 |
Why?
|
Killer Cells, Natural | 3 | 2014 | 24 | 0.310 |
Why?
|
Pyrimidines | 2 | 2018 | 63 | 0.310 |
Why?
|
Gene Expression Profiling | 7 | 2018 | 323 | 0.300 |
Why?
|
Middle Aged | 16 | 2020 | 10678 | 0.300 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 8 | 2014 | 236 | 0.290 |
Why?
|
Receptors, Androgen | 3 | 2007 | 40 | 0.290 |
Why?
|
Epidermal Growth Factor | 3 | 2004 | 19 | 0.290 |
Why?
|
Cells, Cultured | 9 | 2020 | 779 | 0.290 |
Why?
|
Treatment Outcome | 5 | 2018 | 2886 | 0.280 |
Why?
|
Ovarian Neoplasms | 2 | 2020 | 87 | 0.270 |
Why?
|
Estradiol | 7 | 2015 | 120 | 0.270 |
Why?
|
Paracrine Communication | 3 | 2019 | 8 | 0.260 |
Why?
|
Interferon-gamma | 3 | 2018 | 52 | 0.260 |
Why?
|
Estrogen Antagonists | 2 | 2017 | 14 | 0.260 |
Why?
|
Apoptosis | 2 | 2016 | 333 | 0.260 |
Why?
|
Membrane Proteins | 3 | 2017 | 260 | 0.250 |
Why?
|
Gene Expression | 3 | 2017 | 324 | 0.250 |
Why?
|
Osteopontin | 5 | 2009 | 9 | 0.250 |
Why?
|
Proteomics | 3 | 2019 | 86 | 0.250 |
Why?
|
Contraception | 1 | 2003 | 12 | 0.240 |
Why?
|
Blotting, Western | 7 | 2014 | 265 | 0.240 |
Why?
|
Interleukin-6 | 3 | 2020 | 224 | 0.240 |
Why?
|
Mice, Knockout | 6 | 2018 | 392 | 0.240 |
Why?
|
Oligopeptides | 1 | 2003 | 47 | 0.230 |
Why?
|
Cell Line | 6 | 2020 | 418 | 0.230 |
Why?
|
Evidence-Based Medicine | 2 | 2017 | 196 | 0.220 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 28 | 0.220 |
Why?
|
Luteinizing Hormone | 4 | 2014 | 18 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 247 | 0.220 |
Why?
|
Anovulation | 1 | 2002 | 5 | 0.220 |
Why?
|
Fertility Agents, Female | 3 | 2011 | 8 | 0.220 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 619 | 0.210 |
Why?
|
Models, Biological | 4 | 2016 | 356 | 0.210 |
Why?
|
Cell Adhesion | 4 | 2016 | 104 | 0.190 |
Why?
|
Reproduction | 1 | 2020 | 11 | 0.190 |
Why?
|
Galectins | 1 | 2020 | 6 | 0.190 |
Why?
|
Transcription, Genetic | 3 | 2017 | 138 | 0.190 |
Why?
|
Epithelium | 3 | 2006 | 21 | 0.180 |
Why?
|
Cystitis, Interstitial | 1 | 2020 | 37 | 0.180 |
Why?
|
Protein Binding | 3 | 2013 | 182 | 0.180 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 1 | 0.180 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 161 | 0.180 |
Why?
|
Leuprolide | 2 | 2009 | 8 | 0.170 |
Why?
|
Neutrophils | 1 | 2019 | 102 | 0.170 |
Why?
|
Histone Deacetylases | 1 | 2019 | 7 | 0.170 |
Why?
|
Early Diagnosis | 1 | 2019 | 60 | 0.170 |
Why?
|
Exosomes | 1 | 2019 | 37 | 0.170 |
Why?
|
HMGB Proteins | 1 | 2018 | 1 | 0.170 |
Why?
|
SOXF Transcription Factors | 1 | 2018 | 4 | 0.170 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 22 | 0.170 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2012 | 90 | 0.170 |
Why?
|
Phosphorylation | 2 | 2016 | 205 | 0.170 |
Why?
|
Cell Proliferation | 4 | 2019 | 567 | 0.170 |
Why?
|
Inflammation Mediators | 2 | 2017 | 101 | 0.170 |
Why?
|
Choice Behavior | 1 | 2018 | 32 | 0.170 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 64 | 0.170 |
Why?
|
Dyspareunia | 1 | 2018 | 7 | 0.170 |
Why?
|
Adrenomedullin | 1 | 2018 | 4 | 0.170 |
Why?
|
Time Factors | 4 | 2018 | 1874 | 0.170 |
Why?
|
Informed Consent | 1 | 2018 | 50 | 0.170 |
Why?
|
Up-Regulation | 4 | 2018 | 180 | 0.160 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2018 | 15 | 0.160 |
Why?
|
Granulocytes | 1 | 2018 | 12 | 0.160 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2018 | 2 | 0.160 |
Why?
|
Myometrium | 1 | 2018 | 11 | 0.160 |
Why?
|
Blotting, Northern | 3 | 2002 | 23 | 0.160 |
Why?
|
Complement Activation | 1 | 2017 | 10 | 0.160 |
Why?
|
Tristetraprolin | 1 | 2017 | 2 | 0.160 |
Why?
|
Models, Immunological | 1 | 2017 | 10 | 0.160 |
Why?
|
Chemokines | 2 | 2018 | 34 | 0.160 |
Why?
|
Species Specificity | 1 | 2017 | 66 | 0.150 |
Why?
|
L-Selectin | 2 | 2007 | 3 | 0.150 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2017 | 3 | 0.150 |
Why?
|
Decision Making | 1 | 2018 | 154 | 0.150 |
Why?
|
Treatment Failure | 1 | 2017 | 142 | 0.150 |
Why?
|
Alkaline Phosphatase | 1 | 1996 | 35 | 0.150 |
Why?
|
Recurrence | 1 | 2017 | 210 | 0.150 |
Why?
|
Ascitic Fluid | 3 | 2019 | 7 | 0.140 |
Why?
|
Regeneration | 1 | 2018 | 168 | 0.140 |
Why?
|
Fallopian Tube Diseases | 2 | 2007 | 6 | 0.140 |
Why?
|
Mucin-4 | 1 | 2015 | 1 | 0.140 |
Why?
|
Interleukin-17 | 1 | 2015 | 13 | 0.140 |
Why?
|
Nuclear Proteins | 1 | 2015 | 71 | 0.130 |
Why?
|
Follicular Phase | 1 | 2015 | 4 | 0.130 |
Why?
|
Tumor Cells, Cultured | 3 | 2008 | 155 | 0.130 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2014 | 1 | 0.130 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 144 | 0.130 |
Why?
|
Chemokine CXCL13 | 1 | 2014 | 1 | 0.130 |
Why?
|
Germany | 1 | 2014 | 8 | 0.130 |
Why?
|
Interferon Regulatory Factors | 1 | 2014 | 13 | 0.130 |
Why?
|
In Situ Hybridization | 3 | 2003 | 33 | 0.120 |
Why?
|
Neoplasm Proteins | 2 | 2007 | 143 | 0.120 |
Why?
|
COUP Transcription Factor II | 1 | 2013 | 1 | 0.120 |
Why?
|
Systems Biology | 1 | 2013 | 8 | 0.120 |
Why?
|
Rabbits | 3 | 2003 | 181 | 0.120 |
Why?
|
Extracellular Matrix Proteins | 2 | 2004 | 40 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 2013 | 14 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2013 | 43 | 0.120 |
Why?
|
beta Catenin | 1 | 2013 | 37 | 0.120 |
Why?
|
Pregnancy Maintenance | 1 | 2013 | 1 | 0.120 |
Why?
|
Embryo Loss | 1 | 2013 | 2 | 0.120 |
Why?
|
Smoking | 1 | 2016 | 389 | 0.110 |
Why?
|
Peritoneal Cavity | 1 | 2012 | 5 | 0.110 |
Why?
|
Genomics | 1 | 2013 | 78 | 0.110 |
Why?
|
Interleukin-1beta | 2 | 2015 | 40 | 0.110 |
Why?
|
Birth Rate | 1 | 2012 | 2 | 0.110 |
Why?
|
Thyrotropin | 1 | 2011 | 9 | 0.110 |
Why?
|
Prolactin | 1 | 2011 | 7 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2009 | 69 | 0.110 |
Why?
|
Receptors, Estrogen | 1 | 2012 | 90 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 33 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 229 | 0.100 |
Why?
|
Phenotype | 2 | 2020 | 653 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 101 | 0.100 |
Why?
|
Chronic Disease | 1 | 2012 | 359 | 0.100 |
Why?
|
Ultrasonography | 2 | 2011 | 347 | 0.100 |
Why?
|
Principal Component Analysis | 1 | 2011 | 60 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2009 | 73 | 0.100 |
Why?
|
Antigens, Neoplasm | 2 | 2007 | 44 | 0.100 |
Why?
|
Plasmids | 2 | 2020 | 48 | 0.100 |
Why?
|
Selectins | 1 | 2010 | 2 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2011 | 390 | 0.090 |
Why?
|
North Carolina | 1 | 2014 | 1412 | 0.090 |
Why?
|
Apolipoprotein A-I | 1 | 2009 | 68 | 0.090 |
Why?
|
Double-Blind Method | 3 | 2018 | 480 | 0.090 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2008 | 7 | 0.090 |
Why?
|
Pregnancy, Ectopic | 1 | 2008 | 7 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2008 | 110 | 0.080 |
Why?
|
Plant Extracts | 1 | 2008 | 59 | 0.080 |
Why?
|
RNA | 2 | 2016 | 83 | 0.080 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2007 | 2 | 0.080 |
Why?
|
Prevalence | 1 | 2010 | 881 | 0.080 |
Why?
|
Nuclear Receptor Coactivator 1 | 2 | 2009 | 4 | 0.080 |
Why?
|
Histone Acetyltransferases | 2 | 2009 | 5 | 0.080 |
Why?
|
Hot Flashes | 2 | 2018 | 46 | 0.080 |
Why?
|
Autoantibodies | 1 | 2007 | 41 | 0.080 |
Why?
|
Interleukin-8 | 2 | 2017 | 22 | 0.070 |
Why?
|
Mucins | 1 | 2006 | 18 | 0.070 |
Why?
|
Karyotyping | 1 | 2006 | 27 | 0.070 |
Why?
|
Binding, Competitive | 1 | 2006 | 31 | 0.070 |
Why?
|
Estrogen Receptor beta | 1 | 2006 | 12 | 0.070 |
Why?
|
Keratins | 1 | 2006 | 36 | 0.070 |
Why?
|
Amino Acid Sequence | 3 | 2004 | 268 | 0.070 |
Why?
|
Pregnancy, Multiple | 1 | 2005 | 7 | 0.070 |
Why?
|
Molecular Sequence Data | 3 | 2004 | 340 | 0.070 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2006 | 29 | 0.070 |
Why?
|
Choristoma | 2 | 2017 | 17 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 436 | 0.070 |
Why?
|
DNA Fragmentation | 1 | 2005 | 7 | 0.070 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 9 | 0.070 |
Why?
|
Gonadotropins | 1 | 2005 | 5 | 0.070 |
Why?
|
bcl-X Protein | 1 | 2005 | 6 | 0.070 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 12 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 30 | 0.070 |
Why?
|
Collagen | 3 | 2019 | 221 | 0.060 |
Why?
|
Mice, Mutant Strains | 2 | 2015 | 44 | 0.060 |
Why?
|
Estrous Cycle | 1 | 2004 | 3 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2013 | 700 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 46 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 14 | 0.060 |
Why?
|
Fallopian Tubes | 1 | 2003 | 5 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2003 | 50 | 0.060 |
Why?
|
Isoflavones | 1 | 2003 | 65 | 0.060 |
Why?
|
Soybean Proteins | 1 | 2003 | 64 | 0.060 |
Why?
|
Blastocyst | 1 | 2002 | 7 | 0.060 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2002 | 1 | 0.060 |
Why?
|
Receptors, Prostaglandin | 1 | 2002 | 3 | 0.060 |
Why?
|
Growth Substances | 1 | 2002 | 7 | 0.060 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 41 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2002 | 3 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2002 | 3 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 1345 | 0.060 |
Why?
|
Maternal-Fetal Exchange | 1 | 2002 | 5 | 0.050 |
Why?
|
Infertility | 1 | 2002 | 13 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 71 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2002 | 109 | 0.050 |
Why?
|
Androgens | 1 | 2002 | 21 | 0.050 |
Why?
|
Cell Communication | 1 | 2002 | 26 | 0.050 |
Why?
|
Reference Values | 1 | 2002 | 227 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 149 | 0.050 |
Why?
|
Placenta | 1 | 2002 | 64 | 0.050 |
Why?
|
Postmenopause | 1 | 2003 | 398 | 0.050 |
Why?
|
Left-Right Determination Factors | 1 | 2000 | 1 | 0.050 |
Why?
|
Lentivirus | 1 | 2020 | 10 | 0.050 |
Why?
|
Lipids | 2 | 2017 | 215 | 0.050 |
Why?
|
Telomerase | 1 | 2020 | 21 | 0.050 |
Why?
|
Urinary Bladder Diseases | 1 | 2020 | 18 | 0.050 |
Why?
|
Genital Neoplasms, Female | 1 | 2020 | 15 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2019 | 9 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 38 | 0.050 |
Why?
|
Transfection | 1 | 2000 | 184 | 0.050 |
Why?
|
Peritoneum | 1 | 2019 | 24 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2019 | 5 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2020 | 113 | 0.050 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 40 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 63 | 0.040 |
Why?
|
Observer Variation | 2 | 2013 | 96 | 0.040 |
Why?
|
Cell Polarity | 1 | 2018 | 13 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 2018 | 1 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 1 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 12 | 0.040 |
Why?
|
Indazoles | 1 | 2018 | 1 | 0.040 |
Why?
|
Pyridones | 1 | 2018 | 8 | 0.040 |
Why?
|
Multigene Family | 2 | 2014 | 49 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 45 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 151 | 0.040 |
Why?
|
Protein Precursors | 1 | 2018 | 18 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 20 | 0.040 |
Why?
|
Receptors, Interleukin-8B | 1 | 2018 | 4 | 0.040 |
Why?
|
Arginase | 1 | 2018 | 8 | 0.040 |
Why?
|
Postpartum Period | 1 | 2018 | 28 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2018 | 104 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 221 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 2 | 2009 | 72 | 0.040 |
Why?
|
Choriocarcinoma | 1 | 2017 | 1 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 147 | 0.040 |
Why?
|
Cell Movement | 1 | 2018 | 157 | 0.040 |
Why?
|
Protein Transport | 1 | 2017 | 64 | 0.040 |
Why?
|
Gene Silencing | 1 | 2017 | 50 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 164 | 0.040 |
Why?
|
Premenopause | 1 | 2017 | 37 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 156 | 0.040 |
Why?
|
Biological Assay | 1 | 1996 | 14 | 0.040 |
Why?
|
Receptors, Cytokine | 1 | 2016 | 7 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2016 | 15 | 0.040 |
Why?
|
Chemotaxis | 1 | 2016 | 22 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 26 | 0.040 |
Why?
|
Oocyte Retrieval | 1 | 2016 | 2 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2016 | 122 | 0.040 |
Why?
|
Genetic Markers | 1 | 2016 | 134 | 0.040 |
Why?
|
Macrophages | 1 | 2018 | 183 | 0.040 |
Why?
|
Stem Cells | 1 | 2019 | 292 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 80 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 24 | 0.030 |
Why?
|
Chemokine CX3CL1 | 1 | 2015 | 3 | 0.030 |
Why?
|
Hela Cells | 1 | 2015 | 72 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 21 | 0.030 |
Why?
|
Chemokine CXCL1 | 1 | 2015 | 16 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2015 | 25 | 0.030 |
Why?
|
Bone Density | 1 | 2017 | 192 | 0.030 |
Why?
|
alpha-Macroglobulins | 1 | 1995 | 4 | 0.030 |
Why?
|
Pyrophosphatases | 1 | 2015 | 4 | 0.030 |
Why?
|
Microdissection | 1 | 2015 | 3 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 1996 | 521 | 0.030 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2015 | 11 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 40 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2014 | 19 | 0.030 |
Why?
|
Monkey Diseases | 1 | 2014 | 17 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 101 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 55 | 0.030 |
Why?
|
Tissue Donors | 1 | 2016 | 169 | 0.030 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 1 | 2014 | 1 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2014 | 7 | 0.030 |
Why?
|
Aged | 1 | 2007 | 9256 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2014 | 133 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 21 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2005 | 74 | 0.030 |
Why?
|
Binding Sites | 1 | 2013 | 112 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 82 | 0.030 |
Why?
|
Mifepristone | 2 | 2004 | 6 | 0.030 |
Why?
|
Metabolomics | 1 | 2013 | 47 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 102 | 0.030 |
Why?
|
Genome, Human | 1 | 2013 | 148 | 0.030 |
Why?
|
Prognosis | 1 | 2017 | 1342 | 0.030 |
Why?
|
Male | 2 | 2015 | 16967 | 0.030 |
Why?
|
DNA Fingerprinting | 1 | 2012 | 7 | 0.030 |
Why?
|
Tissue Banks | 1 | 2012 | 16 | 0.030 |
Why?
|
Immunoproteins | 1 | 2009 | 1 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 10 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2009 | 95 | 0.020 |
Why?
|
Fibrinogen | 1 | 2009 | 41 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 31 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 27 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 43 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 72 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2009 | 116 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 1 | 2007 | 8 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2008 | 106 | 0.020 |
Why?
|
Immunoblotting | 1 | 2007 | 47 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2007 | 29 | 0.020 |
Why?
|
Organ Size | 1 | 2008 | 204 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2007 | 28 | 0.020 |
Why?
|
Leiomyoma | 1 | 2007 | 16 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2007 | 26 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 2007 | 23 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2006 | 33 | 0.020 |
Why?
|
Mucin-1 | 1 | 2006 | 10 | 0.020 |
Why?
|
Ligands | 1 | 2006 | 59 | 0.020 |
Why?
|
Antibodies | 1 | 2006 | 50 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2006 | 89 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2005 | 9 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 124 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 774 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2007 | 846 | 0.020 |
Why?
|
Base Sequence | 1 | 2004 | 241 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2003 | 8 | 0.020 |
Why?
|
Collagen Type I | 1 | 2003 | 39 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2003 | 29 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 938 | 0.010 |
Why?
|
Peptides | 1 | 2003 | 116 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2003 | 247 | 0.010 |
Why?
|
Tissue Extracts | 1 | 2002 | 1 | 0.010 |
Why?
|
Pregnancy Proteins | 1 | 2002 | 9 | 0.010 |
Why?
|
Basement Membrane | 1 | 2002 | 6 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 50 | 0.010 |
Why?
|
Laminin | 1 | 2002 | 13 | 0.010 |
Why?
|
Pilot Projects | 1 | 2003 | 437 | 0.010 |
Why?
|
Culture Media | 1 | 2002 | 38 | 0.010 |
Why?
|
Proteoglycans | 1 | 2002 | 30 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 79 | 0.010 |
Why?
|
Glycoproteins | 1 | 2002 | 35 | 0.010 |
Why?
|
Cell Division | 1 | 2002 | 97 | 0.010 |
Why?
|
Drug Combinations | 1 | 2002 | 83 | 0.010 |
Why?
|
Cohort Studies | 1 | 2005 | 1673 | 0.010 |
Why?
|
Rats | 1 | 2004 | 1425 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2002 | 430 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1995 | 8 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1998 | 480 | 0.010 |
Why?
|